Medicamen Biotech Balance Sheet Health
Financial Health criteria checks 3/6
Medicamen Biotech has a total shareholder equity of ₹2.0B and total debt of ₹308.2M, which brings its debt-to-equity ratio to 15.4%. Its total assets and total liabilities are ₹2.9B and ₹875.7M respectively. Medicamen Biotech's EBIT is ₹115.6M making its interest coverage ratio 2.8. It has cash and short-term investments of ₹147.9M.
Key information
15.4%
Debt to equity ratio
₹308.17m
Debt
| Interest coverage ratio | 2.8x |
| Cash | ₹147.86m |
| Equity | ₹2.00b |
| Total liabilities | ₹875.67m |
| Total assets | ₹2.95b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 531146's short term assets (₹1.6B) exceed its short term liabilities (₹845.6M).
Long Term Liabilities: 531146's short term assets (₹1.6B) exceed its long term liabilities (₹30.1M).
Debt to Equity History and Analysis
Debt Level: 531146's net debt to equity ratio (8%) is considered satisfactory.
Reducing Debt: 531146's debt to equity ratio has increased from 13.4% to 15.4% over the past 5 years.
Debt Coverage: 531146's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 531146's interest payments on its debt are not well covered by EBIT (2.8x coverage).